Feasibility assessment in topical and transdermal delivery: Mathematical models and in vitro studies

Transdermal Drug Delivery, Second Edition: Revised and Expanded

Volumn , Issue , 2002, Pages 1-23

  Hadgraft, Jonathan ^a   Guy, Richard H ^b,c  

^a UNIVERSITY OF GREENWICH   (United Kingdom)

^b Centre Interuniversitaire de Recherche et d'Enseignement   (France)

^c UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85056976271     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (74)

1. J Hadgraft. Skin, the final frontier. International Journal of Pharmaceutics2001; 224(1-2):1-18.
2. RJ Feldmann, HI Maibach. Regional variation in percutaneous penetration of 14C cortisol in man. Journal of Investigative Dermatology 1967; 48(2): 181-183.
3. BW Barry. Reflections on transdermal drug delivery. Pharmaceutical Science and Technology Today 1999; 2(2):41-43.
4. VM Knepp, J Hadgraft, RH Guy. Transdermal drug delivery—problems and possibilities. CRC Critical Reviews in Therapeutic Drug Carrier Systems 1987; 4(1):13-37.
5. GL Flynn. Physicochemical determinants of skin absorption. In: TR Ger-rity, CJ Henry, eds. Principles of Route-to-Route Extrapolation for Risk Assessment. New York: Elsevier, 1990, pp 93-127.
6. RO Potts, RH Guy. Predicting skin permeability. Pharmaceutical Research1992; 9(5):663-669.
7. SC Valvani, SH Yalkowsky, TJ Roseman. Solubility and partitioning. 4. Aqueous solubility and octanol-water partition-coefficients of liquid nonelectrolytes. Journal of Pharmaceutical Sciences 1981; 70(5):502-507.
8. T Yano, A Nakagawa, M Tsuji, K Noda. Skin permeability of various nonsteroidal anti-inflammatory drugs in man. Life Sciences 1986; 39:1043-1050.
9. T Degim, J Hadgraft, WJ Pugh. Modelling the transdermal delivery of nonsteroidal anti-inflammatory agents. Proceedings of the International Symposium on Controlled Release of Bioactive Materials 1995; 22:652-653.
10. RF-JB Groning. Threedimensional solubility parameters and their use in characterising the permeation of drugs through the skin. Pharmazie 1996; 51:337-341.
11. MS Roberts, WJ Pugh, J Hadgraft. Epidermal permeability: penetrant structure relationships. 2. The effect of H-bonding groups in penetrants on their diffusion through the stratum corneum. International Journal of Pharmaceutics 1996; 132(1-2):23-32.
12. WJ Pugh, MS Roberts, J Hadgraft. Epidermal permeability—penetrant structure relationships. 3. The effect of hydrogen bonding interactions and molecular size on diffusion across the stratum corneum. International Journal of Pharmaceutics 1996; 138(2):149-165.
13. PG Green, J Hadgraft. Facilitated transfer of cationic drugs across a lipoidal membrane by oleic acid and lauric acid. International Journal of Pharmaceutics (Amsterdam) 1987; 37(3):251-256.
14. M Kadono, K Kubo, H Miyazaki, N Tojyo, S Nakagawa, K Miyashita et al. Enhanced in vitro percutaneous penetration of salicylate by ion pair formation with alkylamines. Biological and Pharmaceutical Bulletin 1998; 21(6):599-603.
15. RA Nash, DB Mehta, JR Matias, N Orentreich. The possibility of lidocaine ion pair absorption through excised hairless mouse skin. Skin Pharmacology 1992; 5(3):160-170.
16. C Valenta, U Siman, M Kratzel, J Hadgraft. The dermal delivery of ligno-caine: influence of ion pairing. International Journal of Pharmaceutics 2000; 197(1-2):77-85.
17. J Hadgraft, C Valenta. PH, pK(a) and dermal delivery. International Journal of Pharmaceutics 2000; 200(2):243-247.
18. MS Roberts, YG Anissimov, RA Gonsalvez. Mathematical models in percutaneous absorption. In: RL Bronaugh, HI Maibach, eds. Percutaneous Absorption. New York: Marcel Dekker, 1999, pp 3-55.
19. WJ Albery, J Hadgraft. Percutaneous absorption: theoretical description. J Pharm Pharmacol 1979; 31:129-139.
20. WJ Albery, J Hadgraft. Percutaneous absorption: in vivo experiments. Journal of Pharmacy and Pharmacology 1979; 31(3):140-147.
21. WJ Albery, RH Guy, J Hadgraft. Percutaneous absorption: transport in the dermis. International Journal of Pharmaceutics 1983; 15:125-148.
22. F Pirot, YN Kalia, AL Stinchcomb, G Keating, A Bunge, RH Guy. Characterization of the permeability barrier of human skin in vivo. Proceedings of the National Academy of Sciences of the United States of America 1997; 94(4):1562-1567.
23. AC Watkinson, AL Bunge, J Hadgraft, A Naik. Computer simulation of penetrant concentration-depth profiles in the stratum corneum. International Journal of Pharmaceutics 1992; 87:175-182.
24. YN Kalia, I Alberti, A Naik, RH Guy. Assessment of topical bioavailability in vivo: the importance of stratum corneum thickness. Skin Pharmacology and Applied Skin Physiology 2001; 14:82-86.
25. I Alberti, YN Kalia, A Naik, JD Bonny, RH Guy. In vivo assessment of enhanced topical delivery of terbinafine to human stratum corneum. Journal of Controlled Release 2001; 71(3):319-327.
26. S Riegelman. Pharmacokinetics: pharmacokinetic factors affecting epidermal penetration and percutaneous absorption. Clinical Pharmacology and Therapeutics 1974; 18(5, part 2):873-883.
27. SM Wallace, G Barnett. Pharmacokinetic analysis of percutaneous absorption: evidence of parallel penetration pathways for methotrexate. Journal of Pharmacokinetics and Biopharmaceutics 1978; 6(4):315-325.
28. RH Guy, J Hadgraft, HI Maibach. A pharmacokinetic model for percutaneous absorption. International Journal of Pharmaceutics 1982; 11:119-129.
29. RH Guy, J Hadgraft, HI Maibach. Percutaneous absorption in man: a kinetic approach. Toxicology and Applied Pharmacology 1985; 78(1):123-129.
30. RH Guy, J Hadgraft. The prediction of plasma levels of drugs following transdermal application. Journal of Controlled Release 1985; 1:177-182.
31. RH Guy, J Hadgraft. A theoretical description of the effects of volatility and substantivity on percutaneous absorption. International Journal of Pharmaceutics 1984; 18:139-147.
32. RH Guy, J Hadgraft. Pharmacokinetics of percutaneous absorption with concurrent metabolism. International Journal of Pharmaceutics (Amsterdam) 1984; 20(1-2):43-52.
33. RH Guy, J Hadgraft. Kinetic analysis of transdermal nitroglycerin delivery. Pharmaceutical Research 1985; 2:206-211.
34. J Hadgraft, S Hill, M Humpel, LR Johnston, LR Lever, R Marks, et al.Investigations on the percutaneous absorption of the antidepressant rolipram in vitro and in vivo. Pharmaceutical Research 1990; 7(12):1307-1312.
35. NJ Evans, N Rutter, J Hadgraft, G Parr. Percutaneous administration of theophylline in the preterm infant. Journal of Pediatrics 1985; 107(2):307-311.
36. JN McDougal, HJ Clewell, ME Andersen, GW Jepson. Physiologically based pharmacokinetic modelling of skin penetration. In: RC Scott, RH Guy, J Hadgraft, eds. Prediction of Percutaneous Penetration Methods, Measurements, Modelling, 1990. London: IBC Technical Services, 1990, pp 263-272.
37. GW Jepson, JN McDougal. Physiologically based modeling of nonsteady state dermal absorption of halogenated methanes from an aqueous solution. Toxicology and Applied Pharmacology 1997; 144(2):315-324.
38. B Ongpipattanakul, RR Burnette, RO Potts, ML Francoeur. Evidence that oleic acid exists in a separate phase within stratum corneum lipids. Pharmaceutical Research 1991; 8(3):350-354.
39. A Naik, L Pechtold, RO Potts, RH Guy. Mechanism of oleic acid-induced skin penetration enhancement in vivo in humans. Journal of Controlled Release 1995; 37(3):299-306.
40. D Bommannan, RO Potts, RH Guy. Examination of the effect of ethanol on human stratum corneum in vivo using infrared spectroscopy. Journal of Controlled Release 1991; 16(3):299-304.
41. PK Wotton, B Mollgaard, J Hadgraft, A Hoelgaard. Vehicle effect on topical drug delivery. 3. Effect of azone on the cutaneous permeation of metronidazole and propylene glycol. International Journal of Pharmaceutics1985; 24(1):19-26.
42. MA Pellett, AF Davis, J Hadgraft. Effect of supersaturation on membrane transport. 2. Piroxicam. Int J Pharm 1994; 111:1-6.
43. AF Davis, J Hadgraft. Effect of supersaturation on membrane transport. I. Hydrocortisone acetate. International Journal of Pharmaceutics 1991; 76(1-2):1-8.
44. MA Pellett, AC Watkinson, KR Brain, J Hadgraft. Diffusion of flurbiprofen across human stratum corneum using synergistic methods of enhancement. In: KR Brain, VJ James, KA Walters, eds. Perspectives in Percutaneous Penetration. Cardiff: STS Publishing, 1997, p 86.
45. KR Brain, J Hadgraft, VJ James, VP Shah. In vitro assessment of skin permeation from a transdermal system for the delivery of oestradiol. International Journal of Pharmaceutics 1993; 89(2):R13-R16.
46. PG Green, M Flanagan, B Shroot, RH Guy. Iontophoretic drug delivery. In: KA Walters, J Hadgraft, eds. Pharmaceutical Skin Penetration Enhancement. New York: Marcel Dekker, 1993, pp 311-333.
47. AM Rodriguez Bayon, RH Guy. Iontophoresis of nafarelin across human skin in vitro. Pharmaceutical Research 1996; 13(5):798-800.
48. BH Sage, RA Hoke, Inventors; Becton Dickinson and Company, assignee. Molecules for iontophoretic delivery. US patent 5843015, Dec 11998.
49. R Vanbever, E LeBoulenge, V Preat. Transdermal delivery of fentanyl by electroporation. I. Influence of electrical factors. Pharmaceutical Research1996; 13(4):559-565.
50. R Vanbever, N De Morre, V Preat. Transdermal delivery of fentanyl by electroporation. II. Mechanisms involved in drug transport. Pharm Res 1996; 13:9:1360-1366.
51. S Mitragotri, DA Edwards, D Blankschtein, R Langer. Mechanistic study of ultrasonically-enhanced transdermal drug delivery. Journal of Pharmaceutical Sciences 1995; 84(6):697-706.
52. DF Sarphie, BJ Bellhouse, Y Alexander, KR Brain, J Hadgraft, VJ James, et al. Gas propulsion of microprojectiles for the transdermal delivery of powder form drugs. In: KR Brain, VJ James, KA Walters, eds. Prediction of Percutaneous Penetration, 1993. Cardiff: STS Publishing, 1993, pp 360-368.
53. S Henry, DV McAllister, MG Allen, MR Prausnitz. Microfabricated microneedles: a novel approach to transdermal drug delivery. Journal of Pharmaceutical Sciences 1998; 87(8):922-925.
54. JS Nelson, JL McCullough, TC Glenn, WH Wright, LH Liaw, SL Jacques. Mid-infrared laser ablation of stratum corneum enhances in vitro percutaneous transport of drugs. Journal of Investigative Dermatology 1991; 97(5): 874-879.
55. JP Skelly, VP Shah, HI Maibach, RH Guy, RC Wester, G Flynn, et al. FDA and AAPS report of the workshop on principles and practices of in vitro percutaneous penetration studies—relevance to bioavailability and bioequivalence. Pharmaceutical Research 1987; 4(3):265-267.
56. D Howes, R Guy, J Hadgraft, J Heylings, U Hoeck, F Kemper, et al. Methods for assessing percutaneous absorption—the report and recommendations of ECVAM Workshop 13. ATLA-Alternatives to Laboratory Animals1996; 24(1):81-106.
57. SW Collier, NM Sheikh, A Sakr, JL Lichtin, RF Stewart, RL Bronaugh. Maintenance of skin viability during in vitro percutaneous absorption/me-tabolism studies. Toxicology and Applied Pharmacology 1989; 99(3):522-533.
58. O Doucet, N Garcia, L Zastrow. Skin culture model: a possible alternative to the use of excised human skin for assessing in vitro percutaneous absorption. Toxicology in Vitro 1998; 12(4):423-430.
59. MP Carver, PL Williams, JE Riviere. The isolated perfused porcine skin flap. III. Percutaneous absorption pharmacokinetics of organophosphates, steroids, benzoic acid, and caffeine. Toxicology and Applied Pharmacology1989; 97(2):324-337.
60. JE Riviere, BH Sage, NA Monteiro-Riviere. Transdermal lidocaine iontophoresis in isolated perfused porcine skin. Journal of Toxicology—Cutaneous and Ocular Toxicology 1989; 8(4):493-504.
61. J Hadgraft, D Lewis, D Beutner, HM Wolff. In vitro assessments of transdermal devices containing nitroglycerin. International Journal of Pharmaceutics 1991; 73(2):125-130.
62. J Hadgraft, D Beutner, HM Wolff. In vivo-in vitro comparisons in the transdermal delivery of nitroglycerin. International Journal of Pharmaceutics 1993; 89(1):R1-R4.
63. RH Guy, J Hadgraft. Rate control in transdermal drug delivery? International Journal of Pharmaceutics 1992; 82:R1-R6.
64. J Hadgraft. Pharmaceutical aspects of transdermal nitroglycerin. International Journal of Pharmaceutics 1996; 135(1-2):1-11.
65. I Sarkany, JW Hadgraft, GA Caron, CW Barrett. The role of vehicles in the percutaneous absorption of corticosteroids. An experimental and clinical study. British Journal of Dermatology 1965; 77:569-575.
66. CW Barrett, JW Hadgraft, GA Caron, I Sarkany. The effect of particle size and vehicle on the percutaneous absorption of fluocinolone acetonide. British Journal of Dermatology 1965; 77:576-578.
67. RH Guy, E Tur, S Bjerke, HI Maibach. Are there age and racial differences to methyl nicotinate-induced vasodilatation in human skin? Journal of the American Academy of Dermatology 1985; 12(6):1001-1006.
68. E Benfeldt. In vivo microdialysis for the investigation of drug levels in the dermis and the effect of barrier perturbation on cutaneous drug penetration—studies in hairless rats and human subjects—Preface. Acta Dermato-Venereologica 1999:3-59.
69. A Rougier, D Dupuis, C Lotte, R Roguet. The measurement of the stratum corneum reservoir. A predictive method for in vivo percutaneous absorption studies: influence of application time. Journal of Investigative Dermatology1985; 84(1):66-68.
70. I Alberti, YN Kalia, A Naik, JD Bonny, RH Guy. Effect of ethanol and isopropyl myristate on the availability of topical terbinafine in human stratum corneum, in vivo. International Journal of Pharmaceutics 2001; 219(1-2):11-19.
71. P Xiao, RE Imhof. Optothermal measurement of water distribution within the stratum corneum. Skin Bioengineering 1998; 26:48-60.
72. BD Hanh, RHH Neubert, S Wartewig, A Christ, C Hentzsch. Drug penetration as studied by noninvasive methods: Fourier transform infrared-attenuated total reflection, Fourier transform infrared, and ultraviolet photoacoustic spectroscopy. Journal of Pharmaceutical Sciences 2000; 89(9):1106-1113.
73. PJ Caspers, GW Lucassen, EA Carter, HA Bruining, GJ Puppels. In vivo confocal Raman microspectroscopy of the skin: noninvasive determination of molecular concentration profiles. Journal of Investigative Dermatology2001; 116(3):434-442.
74. E Boelsma, H Tanojo, HE Bodde, M Ponec. An in vivo in vitro study of the use of a human skin equivalent for irritancy screening of fatty acids. Toxicology in Vitro 1997; 11(4):365-376.